CXCL12/CXCR4-Rac1–mediated migration of osteogenic precursor cells contributes to pathological new bone formation in ankylosing spondylitis
H Cui, Z Li, S Chen, X Li, D Chen, J Wang, Z Li… - Science …, 2022 - science.org
Ankylosing spondylitis (AS) is a chronic inflammatory disease characterized by inflammatory
back pain and spinal ankylosis due to pathological new bone formation. Here, we identified …
back pain and spinal ankylosis due to pathological new bone formation. Here, we identified …
CX3CL1 promotes M1 macrophage polarization and osteoclast differentiation through NF-κB signaling pathway in ankylosing spondylitis in vitro
X Feng, S Zhu, J Qiao, Z Ji, B Zhou, W Xu - Journal of Translational …, 2023 - Springer
Background Ankylosing spondylitis (AS) is an autoimmune disease with a genetic
correlation and is characterized by inflammation in the axial skeleton and sacroiliac joints …
correlation and is characterized by inflammation in the axial skeleton and sacroiliac joints …
Abnormal inhibition of osteoclastogenesis by mesenchymal stem cells through the miR-4284/CXCL5 axis in ankylosing spondylitis
W Liu, P Wang, Z Xie, S Wang, M Ma, J Li, M Li… - Cell Death & …, 2019 - nature.com
Ankylosing spondylitis (AS) is a common inflammatory autoimmune disease, characterized
by pathological osteogenesis. Mesenchymal stem cells (MSCs), as the main source of …
by pathological osteogenesis. Mesenchymal stem cells (MSCs), as the main source of …
HLA-B27–mediated activation of TNAP phosphatase promotes pathogenic syndesmophyte formation in ankylosing spondylitis
CH Liu, S Raj, CH Chen, KH Hung… - The Journal of …, 2019 - Am Soc Clin Investig
Ankylosing spondylitis (AS) is a type of axial inflammation. Over time, some patients develop
spinal ankylosis and permanent disability; however, current treatment strategies cannot …
spinal ankylosis and permanent disability; however, current treatment strategies cannot …
MCP1 triggers monocyte dysfunctions during abnormal osteogenic differentiation of mesenchymal stem cells in ankylosing spondylitis
Z Xie, P Wang, J Li, Y Li, S Wang, X Wu, S Sun… - Journal of Molecular …, 2017 - Springer
Ankylosing spondylitis (AS) is a chronic inflammatory disease characterized by pathological
osteogenesis and inflammation. However, the pathogenesis of AS and the pathological …
osteogenesis and inflammation. However, the pathogenesis of AS and the pathological …
Aberrant upregulation of CaSR promotes pathological new bone formation in ankylosing spondylitis
X Li, S Chen, Z Hu, D Chen, J Wang, Z Li… - EMBO Molecular …, 2020 - embopress.org
Pathological new bone formation is a typical pathological feature in ankylosing spondylitis
(AS), and the underlying molecular mechanism remains elusive. Previous studies have …
(AS), and the underlying molecular mechanism remains elusive. Previous studies have …
Targeting chondrocytes for arresting bony fusion in ankylosing spondylitis
F Shao, Q Liu, Y Zhu, Z Fan, W Chen, S Liu, X Li… - Nature …, 2021 - nature.com
Bony fusion caused by pathological new bone formation manifests the clinical feature of
ankylosing spondylitis (AS). However, the underlying mechanism remains elusive. Here we …
ankylosing spondylitis (AS). However, the underlying mechanism remains elusive. Here we …
Chondrogenesis mediates progression of ankylosing spondylitis through heterotopic ossification
T Yu, J Zhang, W Zhu, X Wang, Y Bai, B Feng… - Bone Research, 2021 - nature.com
Ankylosing spondylitis (AS) is chronic inflammatory arthritis with a progressive fusion of axial
joints. Anti-inflammatory treatments such as anti-TNF-α antibody therapy suppress …
joints. Anti-inflammatory treatments such as anti-TNF-α antibody therapy suppress …
Enhanced osteogenic differentiation of mesenchymal stem cells in ankylosing spondylitis: a study based on a three-dimensional biomimetic environment
G Zheng, Z Xie, P Wang, J Li, M Li, S Cen, S Tang… - Cell death & …, 2019 - nature.com
The mechanism of pathological osteogenesis in Ankylosing spondylitis (AS) is largely
unknown. Our previous studies demonstrated that the imbalance between BMP-2 and …
unknown. Our previous studies demonstrated that the imbalance between BMP-2 and …
CXCL8 and CCL20 enhance osteoclastogenesis via modulation of cytokine production by human primary osteoblasts
Generalized osteoporosis is common in patients with inflammatory diseases, possibly
because of circulating inflammatory factors that affect osteoblast and osteoclast formation …
because of circulating inflammatory factors that affect osteoblast and osteoclast formation …
相关搜索
- ankylosing spondylitis stem cells
- ankylosing spondylitis bone formation
- precursor cells bone formation
- ankylosing spondylitis abnormal inhibition
- cd45 cells sdf 1
- aberrant upregulation bone formation
- ankylosing spondylitis aberrant upregulation
- ankylosing spondylitis biomimetic environment
- ankylosing spondylitis bony fusion
- ankylosing spondylitis heterotopic ossification
- ankylosing spondylitis hla b27
- cd45 cells bone marrow
- bone marrow sdf 1
- ankylosing spondylitis precursor cells